Overview
Background
Professor Tim Mercer is Founding Director of the BASE mRNA Facility at the Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, and an NHMRC Leadership Fellow.
BASE is a national NCRIS-supported facility that designs, manufactures and tests mRNA-LNP medicines. Its production facility at the Translational Research Institute supplies mRNA-LNPs to around 120 research laboratories across Australia, and its new clinical manufacturing suites will enable clinical-grade mRNA production. Tim's team develops new methods for mRNA design, manufacture and quality control, including the mRNArchitect design software, a single-step isothermal mRNA synthesis reaction, and nanopore sequencing for mRNA quality control.
Tim trained in computational biology and genomics, and his early work contributed to the discovery of long non-coding RNAs. He has held positions at the Broad Institute, the Max Planck Institute in Dresden, the Centre for Genomic Regulation in Barcelona and the Garvan Institute. He has translated his research into clinical tools, including targeted RNA sequencing, now a first-line diagnostic for cancer fusion genes, and synthetic RNA and DNA controls for clinical genome sequencing.
Tim serves on the Executive Board of the Alliance for mRNA Medicines and chairs its Asia-Pacific Committee.
Availability
- Professor Timothy Mercer is:
- Available for supervision
Fields of research
Qualifications
- Doctor of Philosophy, The University of Queensland
Research interests
-
mRNA design and manufacture
Developing new methods to design and manufacture mRNA medicines. This includes mRNArchitect, software for designing optimised mRNA sequences, and a single-step isothermal reaction that simplifies mRNA synthesis. We apply these tools to build mRNA vaccines and therapies with Australian research and clinical partners.
-
mRNA quality control and reference standards
Using nanopore sequencing to measure mRNA sequence, integrity, 5' capping and poly(A) tails during manufacture. We develop reference standards with partners including NIST to support consistent quality control and regulation of mRNA medicines.
-
Targeted mRNA-LNP delivery
Developing lipid nanoparticles that deliver mRNA to specific cell types, including immune cells for in vivo cell therapies.
-
RNA genomics and long-read sequencing
Studying how the human genome is transcribed using long-read and targeted RNA sequencing. Earlier work contributed to the discovery of long non-coding RNAs and developed targeted RNA sequencing, now a clinical diagnostic for cancer fusion genes.
Research impacts
Tim's research has been translated into clinical diagnostics, industry standards and national manufacturing capability.
- Cancer diagnostics. Tim developed targeted RNA sequencing, which was commercialised with Roche and is now a first-line diagnostic for cancer fusion genes. He raised philanthropic funding to establish the first targeted RNA sequencing fusion-gene test for Australian cancer patients at St Vincent's Hospital, Sydney.
- Genome sequencing standards. Tim developed synthetic RNA and DNA controls for clinical genome sequencing, worked with the US FDA on regulatory recommendations for sequencing-based tests, and co-founded Sequins Pty Ltd to commercialise these standards.
- Sovereign mRNA capability. As Founding Director of BASE, Tim established a national facility that supplies mRNA-LNPs to around 120 research laboratories across Australia, helping researchers develop new mRNA vaccines and therapies.
- mRNA quality control. His team's nanopore sequencing methods for mRNA quality control are used by mRNA manufacturers and are informing international reference standards developed with NIST.
Works
Search Professor Timothy Mercer’s works on UQ eSpace
2022
Journal Article
The potential of long noncoding RNA therapies
Mercer, Tim R., Munro, Trent and Mattick, John S. (2022). The potential of long noncoding RNA therapies. Trends in Pharmacological Sciences, 43 (4), 269-280. doi: 10.1016/j.tips.2022.01.008
2022
Journal Article
ADRAM is an experience-dependent long noncoding RNA that drives fear extinction through a direct interaction with the chaperone protein 14-3-3
Wei, Wei, Zhao, Qiongyi, Wang, Ziqi, Liau, Wei-Siang, Basic, Dean, Ren, Haobin, Marshall, Paul R., Zajaczkowski, Esmi L., Leighton, Laura J., Madugalle, Sachithrani U., Musgrove, Mason, Periyakaruppiah, Ambika, Shi, Jichun, Zhang, Jianjian, Mattick, John S., Mercer, Timothy R., Spitale, Robert C., Li, Xiang and Bredy, Timothy W. (2022). ADRAM is an experience-dependent long noncoding RNA that drives fear extinction through a direct interaction with the chaperone protein 14-3-3. Cell Reports, 38 (12) 110546, 110546. doi: 10.1016/j.celrep.2022.110546
2022
Journal Article
Towards accurate and reliable resolution of structural variants for clinical diagnosis
Liu, Zhichao, Roberts, Ruth, Mercer, Timothy R., Xu, Joshua, Sedlazeck, Fritz J. and Tong, Weida (2022). Towards accurate and reliable resolution of structural variants for clinical diagnosis. Genome Biology, 23 (1) 68, 68. doi: 10.1186/s13059-022-02636-8
2022
Journal Article
The splicing effect of variants at branchpoint elements in cancer genes
Canson, Daffodil M., Dumenil, Troy, Parsons, Michael T., O'Mara, Tracy A., Davidson, Aimee L., Okano, Satomi, Signal, Bethany, Mercer, Tim R., Glubb, Dylan M. and Spurdle, Amanda B. (2022). The splicing effect of variants at branchpoint elements in cancer genes. Genetics in Medicine, 24 (2), 398-409. doi: 10.1016/j.gim.2021.09.020
2022
Journal Article
Using synthetic chromosome controls to evaluate the sequencing of difficult regions within the human genome
Reis, Andre L. M., Deveson, Ira W., Madala, Bindu Swapna, Wong, Ted, Barker, Chris, Xu, Joshua, Lennon, Niall, Tong, Weida, Mercer, Tim R. and on behalf of the SEQC2 Consortium (2022). Using synthetic chromosome controls to evaluate the sequencing of difficult regions within the human genome. Genome Biology, 23 (1) 19, 19. doi: 10.1186/s13059-021-02579-6
2022
Journal Article
Emerging technologies and their impact on regulatory science
Anklam, Elke, Bahl, Martin Iain, Ball, Robert, Beger, Richard D, Cohen, Jonathan, Fitzpatrick, Suzanne, Girard, Philippe, Halamoda-Kenzaoui, Blanka, Hinton, Denise, Hirose, Akihiko, Hoeveler, Arnd, Honma, Masamitsu, Hugas, Marta, Ishida, Seichi, Kass, George EN, Kojima, Hajime, Krefting, Ira, Liachenko, Serguei, Liu, Yan, Masters, Shane, Marx, Uwe, McCarthy, Timothy, Mercer, Tim, Patri, Anil, Pelaez, Carmen, Pirmohamed, Munir, Platz, Stefan, Ribeiro, Alexandre JS, Rodricks, Joseph V ... Slikker Jr., William (2022). Emerging technologies and their impact on regulatory science. Experimental Biology and Medicine, 247 (1), 1-75. doi: 10.1177/15353702211052280
2021
Journal Article
A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of acute myeloid leukemia patients
Ng, Stanley W. K., Murphy, Tracy, King, Ian, Zhang, Tong, Mah, Michelle, Lu, Zhibin, Stickle, Natalie, Ibrahimova, Narmin, Arruda, Andrea, Mitchell, Amanda, Mai, Ming, He, Rong, Madala, Bindu Swapna, Viswanatha, David S., Dick, John E., Chan, Steven M. C., Virtanen, Carl, Minden, Mark D., Mercer, Timothy R., Stockley, Tracy L. and Wang, Jean C. Y. (2021). A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of acute myeloid leukemia patients. Blood Advances, 6 (3), 1064-1073. doi: 10.1182/bloodadvances.2021005741
2021
Journal Article
The Sequencing Quality Control 2 study: establishing community standards for sequencing in precision medicine
Mercer, Tim R., Xu, Joshua, Mason, Christopher E. and Tong, Weida (2021). The Sequencing Quality Control 2 study: establishing community standards for sequencing in precision medicine. Genome Biology, 22 (1) 306, 306. doi: 10.1186/s13059-021-02528-3
2021
Journal Article
Reporting guidelines for human microbiome research: the STORMS checklist
Mirzayi, Chloe, Renson, Audrey, Furlanello, Cesare, Sansone, Susanna-Assunta, Zohra, Fatima, Elsafoury, Shaimaa, Geistlinger, Ludwig, Kasselman, Lora J., Eckenrode, Kelly, van de Wijgert, Janneke, Loughman, Amy, Marques, Francine Z., MacIntyre, David A., Arumugam, Manimozhiyan, Azhar, Rimsha, Beghini, Francesco, Bergstrom, Kirk, Bhatt, Ami, Bisanz, Jordan E., Braun, Jonathan, Bravo, Hector Corrada, Buck, Gregory A., Bushman, Frederic, Casero, David, Clarke, Gerard, Collado, Maria Carmen, Cotter, Paul D., Cryan, John F., Demmer, Ryan T. ... Massive Analysis and Quality Control Society (2021). Reporting guidelines for human microbiome research: the STORMS checklist. Nature Medicine, 27 (11), 1885-1892. doi: 10.1038/s41591-021-01552-x
2021
Journal Article
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing
Fang, Li Tai, Zhu, Bin, Zhao, Yongmei, Chen, Wanqiu, Yang, Zhaowei, Kerrigan, Liz, Langenbach, Kurt, de Mars, Maryellen, Lu, Charles, Idler, Kenneth, Jacob, Howard, Zheng, Yuanting, Ren, Luyao, Yu, Ying, Jaeger, Erich, Schroth, Gary P., Abaan, Ogan D., Talsania, Keyur, Lack, Justin, Shen, Tsai-Wei, Chen, Zhong, Stanbouly, Seta, Tran, Bao, Shetty, Jyoti, Kriga, Yuliya, Meerzaman, Daoud, Nguyen, Cu, Petitjean, Virginie, Sultan, Marc ... Zheng, Yuanting (2021). Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nature Biotechnology, 39 (9), 1151-1160. doi: 10.1038/s41587-021-00993-6
2021
Journal Article
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
Xiao, Wenming, Ren, Luyao, Chen, Zhong, Fang, Li Tai, Zhao, Yongmei, Lack, Justin, Guan, Meijian, Zhu, Bin, Jaeger, Erich, Kerrigan, Liz, Blomquist, Thomas M., Hung, Tiffany, Sultan, Marc, Idler, Kenneth, Lu, Charles, Scherer, Andreas, Kusko, Rebecca, Moos, Malcolm, Xiao, Chunlin, Sherry, Stephen T., Abaan, Ogan D., Chen, Wanqiu, Chen, Xin, Nordlund, Jessica, Liljedahl, Ulrika, Maestro, Roberta, Polano, Maurizio, Drabek, Jiri, Vojta, Petr ... Shi, Leming (2021). Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nature Biotechnology, 39 (9), 1141-1150. doi: 10.1038/s41587-021-00994-5
2021
Journal Article
Long-read cDNA sequencing identifies functional pseudogenes in the human transcriptome
Troskie, Robin-Lee, Jafrani, Yohaann, Mercer, Tim R., Ewing, Adam D., Faulkner, Geoffrey J. and Cheetham, Seth W. (2021). Long-read cDNA sequencing identifies functional pseudogenes in the human transcriptome. Genome Biology, 22 (1) 146, 1-15. doi: 10.1186/s13059-021-02369-0
2021
Journal Article
Testing at scale during the COVID-19 pandemic
Mercer, Tim R. and Salit, Marc (2021). Testing at scale during the COVID-19 pandemic. Nature Reviews Genetics, 22 (7), 415-426. doi: 10.1038/s41576-021-00360-w
2021
Journal Article
Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions
Gong, Binsheng, Li, Dan, Kusko, Rebecca, Novoradovskaya, Natalia, Zhang, Yifan, Wang, Shangzi, Pabón-Peña, Carlos, Zhang, Zhihong, Lai, Kevin, Cai, Wanshi, LoCoco, Jennifer S., Lader, Eric, Richmond, Todd A., Mittal, Vinay K., Liu, Liang-Chun, Johann, Donald J., Willey, James C., Bushel, Pierre R., Yu, Ying, Xu, Chang, Chen, Guangchun, Burgess, Daniel, Cawley, Simon, Giorda, Kristina, Haseley, Nathan, Qiu, Fujun, Wilkins, Katherine, Arib, Hanane, Attwooll, Claire ... Xu, Joshua (2021). Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. Genome Biology, 22 (1) 109, 1-23. doi: 10.1186/s13059-021-02315-0
2021
Journal Article
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Deveson, Ira W., SEQC2 Oncopanel Sequencing Working Group, Gong, Binsheng, Lai, Kevin, LoCoco, Jennifer S., Richmond, Todd A., Schageman, Jeoffrey, Zhang, Zhihong, Novoradovskaya, Natalia, Willey, James C., Jones, Wendell, Kusko, Rebecca, Chen, Guangchun, Madala, Bindu Swapna, Blackburn, James, Stevanovski, Igor, Bhandari, Ambica, Close, Devin, Conroy, Jeffrey, Hubank, Michael, Marella, Narasimha, Mieczkowski, Piotr A., Qiu, Fujun, Sebra, Robert, Stetson, Daniel, Sun, Lihyun, Szankasi, Philippe, Tan, Haowen, Tang, Lin-ya ... Xu, Joshua (2021). Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nature Biotechnology, 39 (9), 1115-1128. doi: 10.1038/s41587-021-00857-z
2021
Journal Article
Chimeric synthetic reference standards enable cross-validation of positive and negative controls in SARS-CoV-2 molecular tests
Madala, Bindu Swapna, Reis, Andre L. M., Deveson, Ira W., Rawlinson, William and Mercer, Tim R. (2021). Chimeric synthetic reference standards enable cross-validation of positive and negative controls in SARS-CoV-2 molecular tests. Scientific Reports, 11 (1) 2636, 1-8. doi: 10.1038/s41598-021-81760-0
2021
Journal Article
The Impact of Variants at Branchpoint Splicing Elements in Cancer Genes
Canson, Daffodil, Dumenil, Troy, Parsons, Michael, O’Mara, Tracy, Davidson, Aimee , Okano, Satomi , Signal, Bethany , Mercer, Tim, Glubb, Dylan and Spurdle, Amanda (2021). The Impact of Variants at Branchpoint Splicing Elements in Cancer Genes. SSRN Electronic Journal, 24 (2), 398-409. doi: 10.2139/ssrn.3933049
2021
Journal Article
Advancing quality-control for NGS measurement of actionable mutations in circulating tumor DNA
Willey, James C., Morrison, Thomas, Austermiller, Brad, Crawford, Erin L., Craig, Daniel J., Blomquist, Thomas M., Jones, wendell D., Wali, Aminah, Lococo, Jennifer S., Haseley, Nathan, Richmond, Todd A., Novoradovskaya, Natalia, Kusko, Rebecca, Chen, Guangchun, Li, Quan-Zhen, Johann, Don, Deveson, Ira W., Mercer, Tim, Wu, Leihong and Xu, Joshua (2021). Advancing quality-control for NGS measurement of actionable mutations in circulating tumor DNA. SSRN Electronic Journal, 1 (7) 100106. doi: 10.2139/ssrn.3830017
2020
Journal Article
Author Correction: Diagnosis of fusion genes using targeted RNA sequencing (Nature Communications, (2019), 10, 1, (1388), 10.1038/s41467-019-09374-9)
Heyer, Erin E., Deveson, Ira W., Wooi, Danson, Selinger, Christina I., Lyons, Ruth J., Hayes, Vanessa M., O’Toole, Sandra A., Ballinger, Mandy L., Gill, Devinder, Thomas, David M., Mercer, Tim R. and Blackburn, James (2020). Author Correction: Diagnosis of fusion genes using targeted RNA sequencing (Nature Communications, (2019), 10, 1, (1388), 10.1038/s41467-019-09374-9). Nature Communications, 11 (1) 1810, 1810. doi: 10.1038/s41467-020-15697-9
2020
Journal Article
A universal and independent synthetic DNA ladder for the quantitative measurement of genomic features
Reis, Andre L. M., Deveson, Ira W., Wong, Ted, Madala, Bindu Swapna, Barker, Chris, Blackburn, James, Marcellin, Esteban and Mercer, Tim R. (2020). A universal and independent synthetic DNA ladder for the quantitative measurement of genomic features. Nature Communications, 11 (1) 3609, 3609. doi: 10.1038/s41467-020-17445-5
Funding
Current funding
Past funding
Supervision
Availability
- Professor Timothy Mercer is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Building the next-generation of mRNA drugs
Principal Advisor
Other advisors: Associate Professor Seth Cheetham
-
Doctor Philosophy
mRNA transient transfection: a novel platform for biopharmaceutical manufacturing production
Associate Advisor
Other advisors: Dr Marianne Gillard, Professor Esteban Marcellin
-
Doctor Philosophy
Targeting transcription factors by restoring tumour suppressors in cancer using mRNA therapy
Associate Advisor
Other advisors: Associate Professor Seth Cheetham
-
Doctor Philosophy
mRNA cancer therapies
Associate Advisor
Other advisors: Dr Christopher Howard, Associate Professor Seth Cheetham
-
Doctor Philosophy
Developing a Predictive Model of mRNA Stability to Inform the Design of mRNA Therapeutics
Associate Advisor
Other advisors: Dr Helen Gunter
-
Doctor Philosophy
Drugging the undruggable with mRNA technologies
Associate Advisor
Other advisors: Associate Professor Seth Cheetham
Completed supervision
-
2015
Doctor Philosophy
RNA CaptureSeq: Targeted Sequencing for Comprehensive Transcriptome Studies
Associate Advisor
Other advisors: Professor Lars Nielsen
Media
Enquiries
For media enquiries about Professor Timothy Mercer's areas of expertise, story ideas and help finding experts, contact our Media team: